PLX Kronos AI forecast
A 30-trading-day price forecast for Protalix BioTherapeutics Inc. (DE) (PLX) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Protalix BioTherapeutics Inc. (DE) at $2.44 on 2026-12-08, −3.6% from the last close of $2.53 on 2026-10-27. Eight out of ten sampled paths end between $2.35 and $2.58, and 2 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of PLX
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $2.61 | $2.48 | $2.69 |
| 2026-11-10 | $2.57 | $2.47 | $2.61 |
| 2026-11-17 | $2.53 | $2.39 | $2.59 |
| 2026-11-24 | $2.52 | $2.43 | $2.64 |
| 2026-12-01 | $2.51 | $2.32 | $2.58 |
| 2026-12-08 | $2.44 | $2.35 | $2.58 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for PLX?
- Kronos AI's median forecast for PLX is $2.44 in 30 trading days, −3.6% from the last close, with a 10–90% range of $2.35 to $2.58.
- Is the PLX Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- AMGN — Amgen Inc.
- GILD — Gilead Sciences Inc.
- MRNA — Moderna Inc.
- ARGX — argenx SE American Depositary Shares
- RVMD — Revolution Medicines Inc.
- BIIB — Biogen Inc.